Literature DB >> 3584500

Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics.

J Neiman, M Hillbom, G Benthin, E E Anggård.   

Abstract

The excretion of 2,3-dinor-6-keto prostaglandin F1 alpha, a major urinary metabolite of prostacyclin, and the formation of thromboxane B2, a stable metabolite of thromboxane A2, by platelets stimulated by adenosine diphosphate, were studied in alcoholics, who had been admitted for detoxification. Once prolonged heavy drinking had stopped, platelet count and thromboxane formation, calculated either per 10(7) platelets or per litre of blood, significantly increased (p less than 0.05), while the skin bleeding time and urinary excretion of the metabolite of prostacyclin decreased (p less than 0.05). The balance between prostacyclin and thromboxane therefore seemed to favour the excretion of prostacyclin while it shifted to favour thromboxane formation about a week later.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584500      PMCID: PMC1141014          DOI: 10.1136/jcp.40.5.512

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Prostaglandin biosynthesis can be triggered by lipid peroxides.

Authors:  M E Hemler; H W Cook; W E Lands
Journal:  Arch Biochem Biophys       Date:  1979-04-01       Impact factor: 4.013

Review 2.  The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.

Authors:  S Bunting; S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

Review 3.  Biology and therapeutic potential of prostacyclin.

Authors:  S Moncada
Journal:  Stroke       Date:  1983 Mar-Apr       Impact factor: 7.914

4.  Quantitative analysis of two dinor urinary metabolites of prostaglandin I2.

Authors:  P Falardeau; J A Oates; A R Brash
Journal:  Anal Biochem       Date:  1981-08       Impact factor: 3.365

5.  Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?

Authors:  G G Serneri; G Masotti; G F Gensini; L Poggesi; R Abbate; M Mannelli
Journal:  Cardiovasc Res       Date:  1981-05       Impact factor: 10.787

6.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

7.  The membrane effects of vitamin E, cholesterol and their acetates on peroxidative susceptibility.

Authors:  J M Gutteridge
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-12

8.  Metabolic disposition of prostacyclin in humans.

Authors:  A R Brash; E K Jackson; C A Saggese; J A Lawson; J A Oates; G A FitzGerald
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

9.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

Review 10.  Effect of alcoholism on hemostasis.

Authors:  D H Cowan
Journal:  Semin Hematol       Date:  1980-04       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.